esomeprazole

2
Generic Name Brand Name Classificati on Mechanism of Action Indications Adverse Reactions Nursing Considerations esomeprazole Dosage: 40 mg IVTT BID Nexium Therapeutic: Antiulcer Pharmacologi c: Proton pump inhibitor Suppresses the final step in gastric acid production by inhibiting the H+/K+-ATPase in the gastric parietal cells. This decreases gastric acid secretion. Risk reduction of NSAID- associated gastric ulcer CNS: headache, anorexia, confusion, dizziness, migraine, sleep disorder, insomnia. CV: hypertension, tachycardia GI: diarrhea, nausea, flatulence, abdominal pain, constipation, melena, vomiting GU: dysmenorrhea, hematuria, cystitis, polyuria Monitor for S&S of adverse CNS effects (vertigo, agitation, depression) especially in severely ill patients. Monitor phenytoin levels with concurrent use. Lab tests: Periodic liver function tests, CBC, Hct & Hbg, urinalysis for hematuria and proteinuria. Patient & Family Education Report any changes in urinary elimination such as pain or

Upload: itsmeaya

Post on 18-Aug-2015

214 views

Category:

Documents


1 download

DESCRIPTION

drug study

TRANSCRIPT

Generic Name Brand Name Classification Mechanism of Action Indications Adverse Reactions Nursing Considerationsesomeprazole Dosage:40 mg IVTT BIDNexium Therapeutic:AntiulcerPharmacologic:Proton pump inhibitorSuppresses the inal step in gastric aci! pro!uction b" inhibiting the #$%&$'ATPase in the gastric parietal cells( This !ecreases gastric aci! secretion()is* re!uction o NSAID'associate! gastric ulcerCNS:hea!ache+ anorexia+ conusion+ !izziness+ migraine+ sleep !isor!er+ insomnia(CV:h"pertension+ tach"car!iaGI:!iarrhea+ nausea+ latulence+ ab!ominal pain+ constipation+ melena+ ,omitingGU: !"smenorrhea+ hematuria+ c"stitis+ pol"uria -onitor or S.S o a!,erse /NS eects 0,ertigo+ agitation+ !epression1 especiall" in se,erel" ill patients( -onitor phen"toin le,els 2ith concurrent use( 3ab tests: Perio!ic li,er unction tests+ /B/+ #ct .#bg+ urinal"sis or hematuria an! proteinuria(Patient!amil" #ducation )eport an" changes in urinar" elimination such aspain or !iscomort associate! 2ith urination to ph"sician( )eport se,ere !iarrhea( Drug ma" nee! to be !iscontinue!(